Selventa has selected John Tagliamonte to serve as senior vice president of corporate development.
In his new role, Tagliamonte will work on establishing strategic partnerships with global pharmaceutical and biotechnology companies.
Prior to joining Selventa (formerly GenStruct), Tagliamonte was vice president of business development at Anchor Therapeutics and led strategy and corporate development efforts at ImmunoGen. He has also held positions at Millipore, Laureate Pharma, and Johnson & Johnson.
Tagliamonte earned his BS from Tufts University and an MBA from Boston College.